Egis Pharmaceuticals Public Limited Company, Hungary
| Държава: | Унгария |
| Кратка информация: | The EGIS PLC in Central Europe's leading pharmaceutical companies. Most important activities of the drug - and substance manufacturing, pharmaceutical research and development , finished products and active trading . Pharmaceuticals Three manufacturing facilities, two in Budapest. One of the Keresztúri road-based company, which substance we produce, the other Bökényföldi road with pills and injekcióüzemünk, csomagolóüzemünk and commercial warehouses operate. Körmendi factory unit in our pills, ointments, suppositories, solutions, syrups and We produce aerosols and packed. Production system meets the international GMP principles and the Hungarian National Institute of Pharmacy standards. Ingredient Production The active ingredient in the manufacture of EGIS t. NYR (and predecessors), a major area of activity. In the earlier decades of professional experience and fölhalmozódott constantly upgraded equipment fleet due to the active production preserves the competitiveness of exports, and by the successful national and international regulatory controls they show good results. The space group is now at about fifty different drug substance and intermediates manufacture. A wide range of individual products characterized by the gradual renewal and replacement. The substance has successfully responded to the recent production of quality and environmental challenges. The strategy is working in the field of computers and commitment of the EGIS fölkészültsége complex is an important part of professional culture. Pharmaceutical Research and Development Research activities in the great market potential for the development of generic and originator pharmaceutical candidates for chemical synthesis of molecular and pharmacological testing of drugs targeted. Developments will focus on cardiovascular diseases, central nervous system, respiratory system and diseases of the digestive tract diseases are drugs. 2010. September 30, ended at the end of 287 valid registered business évünk book was at home and abroad in 2113. Finished products and active trading The Hungarian market, the number of boxes sold under a third of our income is the fifth largest pharmaceutical company. Export market our activities, 73% of our income comes from. The export of finished goods primarily in the eastern regions, Russia and the CIS countries and Central and Eastern European countries aimed at. The western region of the finished product sales, including France and the United Kingdom, while active-and intermediate-exports of France, the Netherlands, Japan and the United States is the most important markets. |
| Сайт: | http://www.egis.hu/ |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
